Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome‐mediated delivery of the Survivin‐T34A mutant

Abstract

This exosomes/Survivin-T34A study shows that a new delivery method for anticancer proteins within the cancer microenvironment may prove useful in targeting cancers of the pancreas.